Xavier Causse

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890

Christophe Hézode, Hélène Fontaine, Céline Dorival et al. · Journal of Hepatology · 2013 · 431 citations

Hepatology, Anrs Co20-cupic, Viral Hepatitis +8

Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis

Christophe Hézode, Hélène Fontaine, Céline Dorival et al. · Gastroenterology · 2014 · 259 citations · Full text

Hepatology, Hepatitis C, Viral Hepatitis +7

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis

Xavier Causse, Hubert Godinot, Michele Chevallier et al. · Gastroenterology · 1991 · 248 citations · Full text

Hepatology, Viral Hepatitis, Liver Physiology +10

Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial

Thierry Thévenot, Christophe Bureau, Frédéric Oberti et al. · Journal of Hepatology · 2014 · 191 citations

Cirrhotic Patients, Microbial Disease, Antibiotics +8

Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: A large multicentre audit with real-life results

Dominique Thabut, Arnaud Pauwels, Nicolas Carbonell et al. · Journal of Hepatology · 2017 · 124 citations

Cirrhotic Patients, Hepatology, Portal Hypertension +8